Avet Pharmaceuticals, Inc. is recalling 15,072 units of Losartan Potassium Tablets USP (50 mg and 100 mg), a prescription medication used to treat high blood pressure. Testing by the FDA confirmed that the tablets contain an impurity called N-Methylnitrosobutyric acid (NMBA) at levels higher than the acceptable daily intake limit. Consumers should contact their healthcare provider or pharmacist immediately for advice on alternative treatments before they stop taking this medication, as the risks of suddenly stopping blood pressure medicine may outweigh the risks of the impurity.
The tablets contain NMBA, which is a known environmental contaminant and a potential human carcinogen. Long-term exposure to this impurity above acceptable safety levels may increase the risk of cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.